Calcium-channel blockers and gingival hyperplasia. (Record no. 1561418)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01076 a2200337 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250511192250.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199205s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1060-0280 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Tam, I M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19920504 |
245 00 - TITLE STATEMENT | |
Title | Calcium-channel blockers and gingival hyperplasia. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The Annals of pharmacotherapy |
Date of publication, distribution, etc. | Feb 1992 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 213-4 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Comparative Study; Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Calcium Channel Blockers |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cardiovascular Diseases |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diltiazem |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gingival Hyperplasia |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nifedipine |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recurrence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Verapamil |
General subdivision | adverse effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wandres, D L |
773 0# - HOST ITEM ENTRY | |
Title | The Annals of pharmacotherapy |
Related parts | vol. 26 |
-- | no. 2 |
-- | p. 213-4 |
No items available.